Targeting a Genomic Biomarker for PET Imaging and Staging of Urothelial Cancer: A Preliminary Evaluation
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2017
At a glance
- Drugs NLS VPAC1 (Primary)
- Indications Bladder cancer; Urogenital cancer
- Focus Diagnostic use
- 03 Oct 2017 Planned End Date changed from 30 Jan 2019 to 30 Jan 2020.
- 03 Oct 2017 Planned primary completion date changed from 30 Jan 2018 to 30 Jan 2019.
- 03 Oct 2017 Status changed from active, no longer recruiting to recruiting.